AnnaMaria DeSalva is chairman and chief executive officer of Hill+Knowlton Strategies, one of the world’s leading public relations companies. Ms. DeSalva previously served as senior advisor to the chief executive officer of DowDuPont, following her role as DuPont’s chief communications officer. Prior to her tenure at DuPont, Ms. DeSalva was head of corporate affairs for biopharmaceutical innovation at Pfizer; served as an advisor to the U.S. Food and Drug Administration; and led the global healthcare practice of Hill & Knowlton. Earlier, at Bristol-Myers Squibb, she led global public affairs for the oncology business and served as the director of the Bristol-Myers Squibb Foundation. Ms. DeSalva is a member of the board of governors of Argonne National Laboratory of the U.S. Department of Energy and serves on the compensation and nominating committees. Additionally, she serves on the boards of directors of the non-profit Project Sunshine and the William & Mary Alumni Association and is a member of the Economic Club of New York. Ms. DeSalva graduated from The College of William & Mary in Williamsburg, Virginia. She has completed the Harvard School of Public Health’s executive education program in risk communication, and the Advanced Health Leadership Program jointly offered by the University of California at Berkeley and Pompeu University in Barcelona, Spain.